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Background: Elevated serum cholesterol level is generally considered to be a risk factor for the development of
cardiovascular diseases which seriously threaten human health. The cholesterol-lowering effects of lactic acid
bacteria have recently become an area of great interest and controversy for many researchers. In this study, we
investigated the effects of two NS lactobacillus strains, Lactobacillus plantarum NS5 and Lactobacillus delbrueckii
subsp. bulgaricus NS12, on lipid metabolism of rats fed a high cholesterol diet.
Methods: Thirty-two SD rats were assigned to four groups and fed either a normal or a high-cholesterol diet. The
NS lactobacillus treated groups received the high-cholesterol diet supplemented with Lactobacillus plantarum NS5
or Lactobacillus delbrueckii subsp. bulgaricus NS12 in drinking water. The rats were sacrificed after a 6-week feeding
period. Body weights, visceral organ and fat weights, serum and liver cholesterol and lipid levels, intestinal
microbiota and liver mRNA expression levels related to cholesterol metabolism were analyzed. Liver lipid deposition
and adipocyte size were evaluated histologically.
Results: Compared with rats fed a high cholesterol diet, serum total cholesterol, low-density lipoprotein cholesterol,
apolipoprotein B and free fatty acids levels were decreased and apolipoprotein A-I level was increased in NS5 or NS12
strain treated rats, and with no significant change in high-density lipoprotein cholesterol level. Liver cholesterol and
triglyceride levels were also significantly decreased in NS lactobacillus strains treated groups. Meanwhile, the NS
lactobacillus strains obviously alleviated hepatic injuries, decreased liver lipid deposition and reduced adipocyte size of
high cholesterol diet fed rats. NS lactobacillus strains restored the changes in intestinal microbiota compositions, such
as the increase in Bacteroides and the decrease in Clostridium. NS lactobacillus strains also regulated the mRNA
expression levels of liver enzymes related to cholesterol metabolism, including the down regulation of acyl-CoA:
cholesterol acyltransferase (ACAT) and the upregulation of cholesterol 7α-hydroxylase (CYP7A1).
Conclusion: This study suggested that the two NS lactobacillus strains may affect lipid metabolism and have
cholesterol-lowering effects in rats fed a high cholesterol diet.
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The incidence of hypercholesterolemia is increasing rap-
idly with the improvements of people’s living standards
and alterations of lifestyles. Hypercholesterolemia is char-
acterized by very high levels of cholesterol in the blood.
Elevated serum cholesterol level is generally considered to* Correspondence: jinfeng@psych.ac.cn; liwang@hznu.edu.cn
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reproduction in any medium, provided the orbe the most important risk factor for the development of
cardiovascular diseases (CVDs), such as hypertension, cor-
onary heart disease, diabetes. The WHO has predicted
that by 2030, approximately 23.6 million people will die
from CVDs and these are projected to remain the single
leading causes of death [1]. It has been reported that even
a 1% decrease in serum cholesterol levels could lower the
risk of coronary heart disease up to 3% [2]. Therefore, low-
ering serum cholesterol levels is one of the effective means
for the prevention of CVDs. There are many commonly
used cholesterol lowering drugs, such as statins are widely
used in clinical practice to lower the serum cholesterolThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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fects of the commonly used drugs, it is more and more at-
tractive to develop more effective and safer alternative
therapies to lower serum cholesterol.
Studies showed that the number and species of intes-
tinal microbiota played an important role in maintaining
normal physiological states of biological organisms and
intestinal microbiota perturbations may potentially lead
to disease states [4]. Stepankova et al. found that the ab-
sence of microbiota (germ-free conditions) accelerated
the atherosclerosis in ApoE-deficient mice fed standard
low cholesterol diet [5]. Studies also found that the gut
microbiota modulated lipid metabolism in mice. The
level of cholesterol in conventionally raised mice was
lower than that of germ-free mice [6]. These facts indi-
cated the existence of the relationship between intestinal
microbiota and hypercholesterolemia. Therefore, effect-
ive interventions in intestinal microbiota may be able to
achieve the purpose of reducing serum cholesterol level.
Lactic acid bacteria (LAB) are widely distributed in hu-
man intestinal and considered to play beneficial effects
on human health by modulating intestinal microbiota
balance [7]. LAB supplementation may be able to reduce
serum cholesterol level. Early in 1974, Mann and Spoerry
firstly discovered the cholesterol-lowering effects of fer-
mented milk ingested by the Massai tribes people [8].
Since then, more and more evidences have suggested the
effects of LAB on serum cholesterol levels in animal
models [9-14] and humans [15-19]. However, conflicting
results have been obtained from different experiments
[20,21]. Therefore, the serum cholesterol-lowering effects
of probiotics are still in debating and the precise mecha-
nisms have not been clearly elucidated. Many possible
mechanisms have been proposed to explain the hypo-
cholesterolemic effects of LAB, such as assimilation of
cholesterol by LAB [22], binding cholesterol to the bacter-
ial cellular surface [23], incorporating cholesterol into
the bacterial cellular membranes [24], converting into
coprostanol by cholesterol reductase produced by LAB
[25-27]. Based on the biological feature of LAB in intes-
tine, we proposed other new possibility that LAB display
the cholesterol-lowering effects by means of modulating
the compositions of intestinal microbiota.
The health benefits of LAB are strain specific and dif-
ferent strains display different beneficial effects [28].
Based on these, a series of lactobacillus strains were iso-
lated from the natural fermented dairy products col-
lected from grassland in Inner Mongolia of China by
our laboratory and were named NS lactobacillus strains.
Firstly, through in vitro experiment, we screened the
strains and found two of them with the highest cholesterol-
lowering abilities, Lactobacillus plantarum NS5 and
Lactobacillus delbrueckii subsp. bulgaricus NS12. In
this study, we examined the effects of the two NSlactobacillus strains on serum and liver lipid levels in
high-cholesterol diet fed male SD rats, and explored
the possible mechanisms from the aspects of intestinal
microbiota compositions and mRNA expression levels
of liver enzymes related to cholesterol metabolism.
Materials and methods
NS lactobacillus strains used in this study
The NS lactobacillus strains used in this study,
Lactobacillus plantarum NS5 [GenBank accession no.
JQ013297] and Lactobacillus delbrueckii subsp. bulgaricus
NS12 [GenBank accession no. JX839763], were two of the
strains isolated from the natural fermented dairy products
collected from grassland in Inner Mongolia of China by
our laboratory. They showed better abilities to lower chol-
esterol in in vitro trials. They were individually inoculated
into MRS media and incubated at 37°C for 24 hours. Then
the lactobacillus strains were collected by centrifugation
at 3000 rpm for 10 minutes and washed twice with normal
saline (0.9% NaCl). The strains were resuspended in sterile
water and used as drinking water at a concentration of
108 CFU/ml (The drinking water was changed every
day, 8–10 ml of water was consumed per 100 g rat body
weight per day).
Animal groups and diets
Thirty-two male Sprague–Dawley rats, conventional clean
animal grade and aged 3 weeks, were purchased from
Vital River Laboratory Animal Ltd. (Beijing, China). They
were fed a normal diet (Keao Xieli Feed Co. Ltd., Beijing,
China) for 1 week. Food and water were supplied ad
libitum. Rats were individually housed in cages and
maintained at a constant temperature (23 ± 2°C) and hu-
midity (55 ± 5%) and exposed to a 12-h light/dark cycle.
The animals were cared for in accordance with the
Guiding Principles in the Care and Use of Animals. All
experiments were approved by the Institutional Animal
Care and Use Committee of the Institute of Psychology of
the Chinese Academy of Sciences.
After 1-week adaptive period on a normal diet con-
taining 32% (weight/weight) protein, 5% fat, 2% fiber,
1.8% calcium, 1.2% phosphorus, and a nitrogen-free ex-
tract as the remainder, the 32 rats were randomly
assigned to four groups of 8 rats each. The four groups
were assigned diets as follows: (1) Control group, nor-
mal diet; (2) HC group, high-cholesterol diet; (3) HC +
NS5 group, high-cholesterol diet with Lactobacillus
plantarum NS5 added in drinking water; (4) HC + NS12
group, high-cholesterol diet with Lactobacillus delbrueckii
subsp. bulgaricus NS12 added in drinking water. The
high-cholesterol diet contained 2% (weight/weight) choles-
terol, 10% lard, 0.3% sodium cholate and 87.7% normal
diet. The rats were fed for 6 weeks and body weight
was recorded. After the feeding period, the rats were
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spleen, lung and kidney) and mesenteric, perirenal and
epididymal white adipose tissues (WAT) were measured.
Assay for blood serum indexes
Before the experiment period (week 0) and at the end of
week 2 and week 4 of the experiment period, the rats were
deprived of food for 12 hours, and then 100 μl blood sam-
ples were collected with capillary tubes from the tail vein
and were used to analyze the serum cholesterol content.
By the end of the experiment period (week 6), about 5 ml
blood samples from each rat were collected into tubes
using cardiac puncture following food deprivation for 12
hours. The serum was separated from the blood by centri-
fugation at 3500 rpm for 10 minutes. The total cholesterol
(TC), high density lipoprotein cholesterol (HDL-C), low
density lipoprotein cholesterol (LDL-C) were measured
with automatic chemical analyzer. Serum free fatty acids
were estimated using an ultrasensitive assay kit for free
fatty acids (Applygen Technologies Inc., Beijing). Apoli-
poprotein A-I (ApoA-I) and apolipoprotein B (ApoB)
were analyzed with rat ApoA-I and ApoB ELISA kit
(Bio-function Technology Ltd., Beijing) according to the
manufacturer’s recommended protocol.
Assay for liver TC and TG
After the rats had been killed, the livers were removed
and rinsed with physiological saline solution, blotted dry
with filter paper and weighed. Liver total cholesterol
(TC) and triglyceride (TG) contents were determined
using tissue total cholesterol and triglyceride assay kit
(Applygen Technologies Inc., Beijing) according to the
manufacturer’s instructions.
Histopathology of liver and adipocytes
After euthanasia, rat livers and adipocytes were re-
moved and frozen rapidly to about −20 to −30°C. The
specimens were then embedded in optimal cutting
temperature (OCT) compound (Sakura Finetek USA
Inc., USA) and subsequently they were cut frozen with
Leica CM1900 Cryostat. The sections were picked up
on a glass slide and stained. The liver specimens were
stained with hematoxylin-eosin (HE) or oil red O. The
adipocytes specimens were also stained with HE and
adipocyte numbers were counted in 3 different spots
per rat.
Intestinal microbiota analysis
Fecal samples were collected at sacrifice and frozen at −
20°C. Bacterial DNA was extracted using a TIANamp
stool DNA kit (Tiangen Biotech Co. Ltd., Beijing,
China) following the manufacturer’s instructions. DNA
was amplified by qPCR using SYBR® Premix Ex Taq™
(Takara, Japan) and primer sets (Table 1) designed for16S rRNA of bacterial species including Eubacteria
(all bacteria; used as housekeeping gene), Firmicutes,
Bacteroides and Clostridium to analyze intestinal micro-
biota between different groups. Results were presented as
percentage expression of each species relative to total bac-
teria (Eubacteria).
mRNA expression levels
The mRNA expression levels of liver enzymes associated
with cholesterol metabolism were analyzed. Total RNA
was isolated from rat liver by TRIZOL reagent (Tiangen
Biotech Co. Ltd., Beijing, China) according to the manu-
facturer’s protocol. The RNA concentration was esti-
mated by measurement with a UV spectrophotometer at
260 and 280 nm and transcribed into cDNA (Tiangen
Biotech Co. Ltd., Beijing, China). The mRNA expression
of genes was measured by RT-PCR using SYBR® Premix
Ex Taq™ (Takara, Japan), with values presented as 2-ΔΔCT.
We used the housekeeping gene for glyceraldehyde-
3-phosphate dehydrogenase (GAPDH; EC1.2.1.12) for
normalization. The genes and primer sequences used
for RT-PCR are described in Table 1.
Statistical analysis
All experimental data were presented as the mean ±
standard deviations (SD). Data were analyzed using a
one-way analysis of variance using SPSS 17.0 statistical
software (SPSS Inc., Chicago, IL, USA); Values of p < 0.05
were considered statistically significant.
Results
The growth of rats and the weight of visceral organs
At the beginning and end of the experimental period, the
body weight of rats in all four groups was recorded. All
the rats used in this study appeared healthy throughout
the whole feeding period. The initial body weight of rats
showed no significant difference between groups. After 6
weeks of experimental period, the rats in HC group which
fed a high-cholesterol diet exhibited an increasing trend in
body weight compared with control group which fed a
normal diet, but not yet reached to statistical significance
(441.9 ± 16.3 vs. 415.7 ± 30.1 g, p = 0.070). Adding 108
CFU/ml of Lactobacillus plantarum NS5 (HC +NS5
group) or Lactobacillus delbrueckii subsp. bulgaricus
NS12 (HC +NS12 group) in drinking water, they showed
a slight decrease in final body weight compared with HC
group, but also without significant difference (Table 2).
After the rats were killed, the visceral organs (heart,
liver, spleen, lung and kidney) and mesenteric, perirenal
and epididymal white adipose tissues (WAT) were sepa-
rated and weighed (Table 3). The rats had the lowest
liver weight in control group and had the highest liver
weight in HC group. Lactobacillus plantarum NS5 sig-
nificantly lowered liver weight as compared with the HC
Table 1 Primer sequences used in this study
Target Forward (5′-3′) Reverse (5′-3′)
Intestinal microbiota
Eubacteria ACTCCTACGGGAGGCAGCAGT ATTACCGCGGCTGCTGGC
Firmicutes GGAGYATGTGGTTTAATTCGAAGCA AGCTGACGACAACCATGCAC
Bacteroides GAGAGGAAGGTCCCCCAC CGCTACTTGGCTGGTTCAG
Clostridium ACTCCTACGGGAGGCAGC GCTTCTTAGTCAGGTACCGTCAT
mRNA
GAPDH GCAAGTTCAACGGCACAG CGCCAGTAGACTCCACGAC
HMG-CoA R TGTGGGAACGGTGACACTTA CTTCAAATTTTGGGCACTCA
LDLR AGCCGATGCATTCCTGACTC AGTTCATCCGAGCCATTTTCAC
CYP7A1 ACGTGGTTGGAAGAAGCG GAATGTGGGCAGCGAGAA
ACAT GCTGAAGTGAACTACCCCTT GAGCCATGCCTCTAGTACCT
LCAT CCCAAGGCTGAACTCAGTAACCA CGGTAGCACAGCCAGTTTACCA
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NS12 also lowered the liver weight, but without statistical
significance (p = 0.064). There were no significant differ-
ences in the weight of hearts, spleens, lungs and kidneys
among the four groups. Similarly, control group had the
lowest WAT weight and HC group had the highest WAT
weight, but not yet reached to statistical significance.Effect of NS5 and NS12 strains on serum lipids
Blood serum total cholesterol (TC) levels in the four
groups were shown in Figure 1A. Before the experiment,
serum TC showed no significant difference between
groups. High-cholesterol diets could significantly increase
serum TC levels compared with control group. Lactobacillus
plantarum NS5 and Lactobacillus delbrueckii subsp.
bulgaricus NS12 showed varying degrees of cholesterol-
lowering abilities in vivo. Compared with the HC group,
NS5 strain significantly lowered the serum TC levels. At the
end of 2 weeks and 4 weeks, the serum TC levels in HC+
NS5 group were still different from control group with stat-
istical significance, but at the end of 6 weeks, there was even
no significant difference compared with control group.
NS12 strain also reduced the serum TC levels to some
extent compared with HC group, but without statisticalTable 2 Body weight changes of rats between groups
after 6 weeks
Group Rats (n) Initial weight (g) Final weight (g)
Control 8 89.4 ± 10.3 415.7 ± 30.1
HC 8 90.3 ± 7.9 441.9 ± 16.3
HC + NS5 8 89.4 ± 7.5 426.8 ± 24.6
HC + NS12 8 90.7 ± 8.3 428.0 ± 22.6
Control: normal diet; HC, high cholesterol diet; HC+NS5, high cholesterol diet +
Lactobacillus plantarum NS5; HC+NS12, high cholesterol diet + Lactobacillus
delbrueckii subsp. bulgaricus NS12.
The data are shown as the mean ± standard deviation.significance. However, there was also no significant differ-
ence between HC+NS5 and HC+NS12 groups.
The control group displayed the highest HDL-C level,
and high-cholesterol diets reduced the serum HDL-C
concentration. But the NS5 and NS12 strains did not
show obvious influences on HDL-C levels compared
with HC group. However, the elevated serum LDL-C
levels induced by feeding high-cholesterol diets were re-
duced in the NS5 and NS12 strains treated groups. HC +
NS5 group showed a statistical significant difference
and the difference was not significant in HC + NS12
group (Figure 1B). Atherogenic indexes (TC/HDL-C
and LDL-C/HDL-C ratios) were calculated (Figure 1C).
The HC group demonstrated the highest and the control
group demonstrated the lowest atherogenic indexes in all
the four groups (TC/HDL-C: 3.57 ± 0.82 vs. 1.84 ± 0.08,
p < 0.05 and LDL-C/HDL-C: 2.10 ± 0.76 vs. 0.30 ± 0.05,
p < 0.05). The NS5 and NS12 strains significantly lowered
the TC/HDL-C and LDL-C/HDL-C ratios comparing
with the HC group. Although NS5 strains seemed more
effective than NS12 strains, there were no significant
differences in lowering the atherogenic indexes between
the two groups.
Apolipoprotein A-I(ApoA-I) and apolipoprotein B (ApoB)
in serum were also analyzed. High-cholesterol diets signifi-
cantly lowered the serum ApoA-I level and increased the
ApoB level (Figure 2A). The NS12 strain significantly
increased the serum ApoA-I level compared with HC group
(p < 0.05) and with no difference from control group
(p > 0.05). The rise of ApoA-I in HC+NS5 group was not
statistical significant compared with HC group (p > 0.05).
However, they were also not significantly different from con-
trol group and HC+NS12 group. NS5 and NS12 strains
displayed a trend to decrease the ApoB level comparing with
HC group, but there were no statistical significance. Never-
theless, there were also no differences compared with
control group. ApoB1/ApoA-I ratio was also calculated and
Table 3 Effect of NS5 and NS12 on visceral organs and WAT weight in rats
Weight (g) Control (n = 8) HC (n = 8) HC + NS5 (n = 8) HC + NS12 (n = 8)
Heart 1.5 ± 0.2 1.5 ± 0.1 1.5 ± 0.2 1.4 ± 0.2
Liver 14.4 ± 1.4a 22.2 ± 3.1b 18.7 ± 2.1c 19.3 ± 3.7bc
Spleen 0.9 ± 0.2 0.9 ± 0.1 0.7 ± 0.3 0.8 ± 0.2
Lung 2.3 ± 0.3 2.3 ± 0.3 2.3 ± 0.2 2.2 ± 0.4
Kidney 3.4 ± 0.7 3.2 ± 0.4 3.0 ± 0.3 3.3 ± 0.7
Epididymal fat 4.7 ± 1.3 6.2 ± 1.2 5.2 ± 1.2 4.9 ± 1.5
Perirenal fat 6.6 ± 1.6 8.2 ± 2.1 7.2 ± 2.4 6.5 ± 1.7
Mesenteric fat 5.5 ± 1.1 6.5 ± 1.0 5.8 ± 0.9 5.5 ± 1.8
Control: normal diet; HC, high cholesterol diet; HC + NS5, high cholesterol diet + Lactobacillus plantarum NS5; HC + NS12, high cholesterol diet + Lactobacillus
delbrueckii subsp. bulgaricus NS12.
The data are shown as the mean ± standard deviation.
a,b,c Mean values within a row with different superscript letters differ significantly (p < 0.05).
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all four groups. NS5 and NS12 strains could decrease the ra-
tios compared with HC group (Figure 2B).
Serum free fatty acids (FFA) were also significantly in-
creased after feeding high-cholesterol diets. Adding NS5
and NS12 strains to drinking water could lower theFigure 1 Effects of the two NS lactobacillus strains on serum
cholesterol in rats fed a high cholesterol diet. (A) Serum total
cholesterol content; (B) Serum HDL-C and LDL-C; (C) Atherogenic
indexes of the rats, TC/HDL-C and LDL-C/HDL-C ratios. The data are
shown as the mean ± standard deviation. Control: normal diet; HC:
high cholesterol diet; HC + NS5: high cholesterol diet + Lactobacillus
plantarum NS5; HC + NS12: high-cholesterol diet + Lactobacillus
delbrueckii subsp. bulgaricus NS12. a,b,c Mean values in each panel
with different superscript letters differ significantly (p < 0.05).serum FFA levels to the extent that have no difference
with control group (Figure 3).
NS5 and NS12 strains reduced liver TC and TG levels in
rats fed a high-cholesterol diet
Liver TC levels differed significantly among the four
groups (Figure 4A). The liver TC levels of rats fed a high-
cholesterol diet had greatly increased compared with con-
trol group. NS5 and NS12 strains could significantly
reduce the liver TC levels comparing with HC group; and
NS12 was more effective than NS5.
The control group displayed the lowest liver TG level
and HC group displayed the highest liver TG level. Both
the HC +NS5 and HC +NS12 groups had lower levels
of liver TG than HC group (p < 0.05) and there were no
obvious differences between the two NS lactobacillus
groups (Figure 4B).
Histopathology of liver and adipocytes
Figure 5 illustrated the effects of Lactobacillus plantarum
NS5 and Lactobacillus delbrueckii subsp. bulgaricus NS12
on hepatic steatosis. Hematoxylin-eosin (HE) and oil red
O staining showed the differences in liver tissue structures
and lipids accumulation of the four groups. The rat livers
of control group had a well-organized structure. Hepatic
sinusoids were clearly visible and hepatic cords were
neatly arranged and distributed radially around the central
veins. The structures of livers displayed large degrees of
damages in HC group, and hepatocytes showed signs of
necrosis. Hepatocyte steatosis was obviously alleviated by
adding NS5 and NS12 strains to drinking water compared
with HC group (Figure 5A). Oil red O staining suggested
that many massive lipid droplets were accumulated in the
liver tissues in HC group and the lipid droplets had obvi-
ously decreased in HC +NS5 and HC +NS12 groups
(Figure 5B).
The rats in HC group demonstrated increased adipo-
cyte size comparing with control groups (Figure 6A).
Figure 2 Effects of the two NS lactobacillus strains on serum apolipoprotein in rats fed a high cholesterol diet. (A) Serum ApoA-I and
ApoB; (B) Serum ApoB/ApoA-I ratio. The data are shown as the mean ± standard deviation. Control: normal diet; HC: high cholesterol diet; HC +
NS5: high cholesterol diet + Lactobacillus plantarum NS5; HC + NS12: high-cholesterol diet + Lactobacillus delbrueckii subsp. bulgaricus NS12. a,b
Mean values in each panel with different superscript letters differ significantly (p < 0.05).
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cyte number per spot. The more the adipocyte number
was, the smaller the adipocyte size was. The adipocyte
size was partly restored by NS5 and NS12 strains.
NS5 and NS12 strains recovered the changes of intestinal
microbiota caused by high-cholesterol diets
No significant difference was observed in fecal Firmicutes
of rats in all the four groups (Figure 7A). There was the
lowest percentage of Bacteroides in feces of rats fed a
high-cholesterol diet, but without statistical significance
compared with control group. After feeding with NS5 and
NS12 strains, the percentage of Bacteroides was obviouslyFigure 3 Effects of the two NS lactobacillus strains on serum
free fatty acids in rats fed a high cholesterol diet. The data are
shown as the mean ± standard deviation. Control: normal diet; HC:
high cholesterol diet; HC + NS5: high cholesterol diet + Lactobacillus
plantarum NS5; HC + NS12: high-cholesterol diet + Lactobacillus
delbrueckii subsp. bulgaricus NS12. a,b Mean values in each panel
with different superscript letters differ significantly (p < 0.05).increased comparing with HC groups (Figure 7B). High-
cholesterol diet resulted in an increase in Clostridium,
which was ameliorated after treated with NS lactobacillus
strains (Figure 7C). The percentages of Clostridium in
HC+NS5 and HC+NS12 groups were not different from
control group.
mRNA expression levels of liver enzymes associated with
cholesterol metabolism
The mRNA expression levels of hepatic enzymes associ-
ated with cholesterol metabolism were illustrated in
Figure 8. HMG-CoA reductase (HMG-CoA R) is the rate-
limiting enzyme in hepatic cholesterol de novo synthesis,
catalyzing the conversion of HMG-CoA to mevalonic acid.
Its mRNA expression levels were reduced by 50%, 64%
and 55% in HC, HC +NS5 and HC +NS12 groups com-
pared to control group, respectively. The HMG-CoA R
mRNA level in HC + NS5 group was the lowest. LDLR
is a receptor on the hepatocyte surface that mediates the
endocytosis of LDL-cholesterol. Its mRNA expression
levels were all decreased in the three high-cholesterol
diet fed groups and the level of HC + NS12 group was
the highest among the three groups. Cholesterol 7α-
hydroxylase (CYP7A1) is the enzyme in the synthesis of
bile acid from cholesterol. Its mRNA expression levels
in HC, HC + NS5 and HC + NS12 groups were 2.44-,
3.72- and 4.65-fold higher than control group respect-
ively; and the HC + NS12 group had the highest level.
Acyl-CoA:cholesterol acyltransferase (ACAT) is the en-
zyme responsible for esterification of cholesterol, and
its mRNA expression level in HC group was signifi-
cantly higher than control group. NS5 and NS12 strains
decreased the levels compared with HC group, but there
were no statistical significance. However, there were also
no differences compared with control group. The lecithin
cholesterol acyltransferase (LCAT) mRNA expression in
all the four groups were not significantly different.
Figure 4 Effects of the two NS lactobacillus strains on liver cholesterol and triglyceride in rats fed a high cholesterol diet. (A) Liver total
cholesterol; (B) Liver triglyceride. The data are shown as the mean ± standard deviation. Control: normal diet; HC: high cholesterol diet; HC + NS5:
high cholesterol diet + Lactobacillus plantarum NS5; HC + NS12: high-cholesterol diet + Lactobacillus delbrueckii subsp. bulgaricus NS12. a,b,c,d Mean
values in each panel with different superscript letters differ significantly (p < 0.05).
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Cardiovascular diseases (CVDs) are the most important
cause of death in the world, including China. Hyperchol-
esterolemia is strongly associated with coronary heart
disease [29]. HDL-C can prevent CVDs such as arterio-
sclerosis by removing cholesterol from the blood stream,
whereas LDL-C causes accumulation of cholesterol in
blood vessels. TC/HDL-C and LDL-C/HDL-C ratios are
recognized as two important indicators of CVDs risk
with greater predictive value than isolated parameters
used independently [30]. The higher the ratios are, the
greater the CVDs risk is. Therefore, reduction of serum
total cholesterol (TC) and LDL-C and increase of HDL-
C may be an important treatment option for CVDs.
Probiotics are defined as “living microbial supplements
that beneficially affect the host animals by improving its
intestinal microbial balances” [31]. In this study, we used
two NS lactobacillus strains isolated from natural
fermented dairy products collected from grassland in
Inner Mongolia of China, Lactobacillus plantarum NS5
and Lactobacillus delbrueckii subsp. bulgaricus NS12.
We found that NS5 strain could significantly reduce the
serum TC and LDL-C levels (reduced by 18.11% and
33.33%, respectively) compared to rats fed with high-
cholesterol diet by the end of 6 weeks. Similar results were
previously reported in other Lactobacillus plantarum
strains [12,13]. NS12 strain also reduced the levels of TC
and LDL-C (reduced by 12.83% and 22.44%, respectively),
but there were no statistical significances compared with
HC group. However, there was also no significant differ-
ence with NS5 strains. They all didn’t obviously influence
HDL-C levels. Meanwhile, both NS5 and NS12 strains sig-
nificantly reduced the TC/HDL-C (23.25% vs. 15.41%) and
LDL-C/HDL-C ratios (37.14% vs. 23.81%) and NS5 strain
seemed more effective than NS12 strain. Liver cholesterol
levels were also examined. NS5 and NS12 strains all obvi-
ously decreased the cholesterol levels in liver comparedwith HC group, but contrary to the results of serum TC,
NS12 was more effective than NS5 in liver cholesterol
lowering activity (34.58% vs. 13.47%). These results maybe
suggested that NS5 strain was more effective in reducing
cholesterol absorption and increasing serum cholesterol
removal and NS12 strain was more effective in reducing
liver cholesterol synthesis and accumulation.
ApoA-I is the principal apolipoprotein in HDL and
ApoB represents most of the protein content in LDL.
The apoB/apoA-I ratio is also a strong risk factor for
predicting CVDs [32]. Studies even suggested that the
ApoB/ApoA-I ratio was better than the TC/HDL-C and
LDL-C/HDL-C ratios to estimate the balance between
the serum proathergenic and antiatherogenic lipopro-
teins and to predict CVDs risk [33]. NS5 and NS12
strains displayed significant effects on decreasing ApoB/
ApoA-I ratio.
There is an increasing recognition about the potential
role for serum free fatty acids (FFA) in CVDs [34]. In
this study, we found elevated serum FFA levels in rats
fed high-cholesterol diets, and NS5 and NS12 strains
significantly decreased the FFA levels. Research found
that an increase in serum FFA induced markers of endo-
thelial activation, vascular inflammation and thrombosis
and suggested that increases in serum FFA may initiate
early vascular abnormalities then promote CVDs [35].
These results suggested that the NS5 and NS12 strains
could reduce the risk of incidence of CVDs.
Generally considered, high-cholesterol diets could in-
crease the body weight. In this study, high-cholesterol
diets induced the increase of body weight, but did not
statistical significant (p = 0.070). NS5 and NS12 slightly
decreased the body weight compared with HC group,
but also without significant difference. The same results
were observed in WAT weights. This may be associated
with the dose and method of strains used and the length
of treatment. But we still believe NS5 and NS12 strains
Figure 5 Effects of the two NS lactobacillus strains on histology of liver in rats fed a high cholesterol diet. (A) Representative
photomicrographs of hematoxylin and eosin staining (100×); (B) Representative photomicrographs of oil red O staining (200×). Control: normal
diet; HC: high cholesterol diet; HC + NS5: high cholesterol diet + Lactobacillus plantarum NS5; HC + NS12: high-cholesterol diet + Lactobacillus
delbrueckii subsp. bulgaricus NS12.
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http://www.lipidworld.com/content/12/1/67have a potentiality to reduce the body weight. Mean-
while, we found that high-cholesterol diets obviously in-
creased liver weight and it was significantly reduced by
NS5 strains. Liver TG levels were also analyzed, and
NS5 and NS12 strains significantly reduced the storage
of TG in rats liver. This was also proved by the observa-
tion of oil red O staining of liver tissues. Histopathology
of liver also suggested severe injuries in liver tissues ofhigh-cholesterol diets fed rats, and NS5 and NS12
strains partially ameliorated the injuries.
Intestinal microbiota modulates host energy and lipid
metabolism [6]. Studies also suggested that high-fat feed-
ing induces changes of intestinal microbiota which was as-
sociated with an increased intestinal permeability and
consequently triggered inflammation and metabolic disor-
ders [36]. Ley et al. reported that the relative abundance of
Figure 6 Effects of the two NS lactobacillus strains on adipocyte size in rats fed a high cholesterol diet. (A) Representative
photomicrographs of hematoxylin and eosin staining of adipocytes (200×); (B) Adipocyte numbers in 3 different spots per rat. The data are
shown as the mean ± standard deviation. a,b,c Mean values in each panel with different superscript letters differ significantly (p < 0.05). Control:
normal diet; HC: high cholesterol diet; HC + NS5: high cholesterol diet + Lactobacillus plantarum NS5; HC + NS12: high cholesterol diet +
Lactobacillus delbrueckii subsp. bulgaricus NS12.
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http://www.lipidworld.com/content/12/1/67the Bacteroides in obese mice was lower, whereas the
Firmicutes was higher [37]. And the obesity-associated in-
testinal microbiota has an increased capacity to harvest
energy from the diet [38]. The high-cholesterol diet did
not alter the proportion of Firmicutes, but the proportion
of Bacteroides was the lowest in rats fed a high-cholesterol
diet. NS5 and NS12 strains increased the proportion of
Bacteroides. The increased body weight in HC group
was probably because of the decreased proportion of
Bacteroides which increased the energy harvesting from
the diet. NS5 and NS12 strains increased the proportion
of Bacteroides and resulted in the reduction of body
weight to some extent. We also found Clostridium wassignificantly increased in high-cholesterol diets fed rats,
and NS5 and NS12 strains restored the changes. These re-
sults suggested that high-cholesterol diets induced the
alteration in intestinal microbiota compositions and con-
sequently led to metabolic disorders, and finally resulted
in increased serum cholesterol. This also suggested that
serum cholesterol-lowering effects of NS5 and NS12
strains may be attributed to the restore of intestinal micro-
biota compositions by the two NS lactobacillus strains. In-
testinal microbiota also acts as an environmental factor
regulating fat storage [39]. In our study, the WAT weight
was the highest in rats fed a high-cholesterol diet, and
NS5 and NS12 strains reduced the weight of WAT. This
Figure 7 Effects of the two NS lactobacillus strains on intestinal microbiota compositions in rats fed a high cholesterol diet. (A)
Percentage of Firmicutes relative to Eubacteria; (B) Percentage of Bacteroides relative to Eubacteria; (C) Percentage of Chostridium relative to
Eubacteria. The data are shown as the mean ± standard deviation. Control: normal diet; HC: high cholesterol diet; HC + NS5: high cholesterol
diet + Lactobacillus plantarum NS5; HC + NS12: high-cholesterol diet + Lactobacillus delbrueckii subsp. bulgaricus NS12. a,b,c,d Mean values in each
panel with different superscript letters differ significantly (p < 0.05).
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http://www.lipidworld.com/content/12/1/67may be also because of the high-cholesterol diets induced
the changes in intestinal microbiota compositions. On the
other hand, NS5 and NS12 strains also reduced the adipo-
cyte size in rats fed a high-cholesterol diet. Therefore, NS5
and NS12 strains may exert a beneficial effect on the high-
cholesterol diets induced increase in WAT weight partly
by reducing the cell size of adipocyte.
The serum cholesterol level is regulated by three dis-
tinct pathways: absorption, synthesis and excretion.
LDLR is a receptor on the hepatocyte surface that medi-
ates the endocytosis of LDL-C and the mRNA expres-
sion level of LDLR was negatively correlated with
cellular cholesterol content [40]. High cholesterol diets
significantly decreased the mRNA expression level of
LDLR, therefore resulted in increase of serum LDL-C
level. NS5 strain did not alter LDLR expression level andFigure 8 Effects of the two NS lactobacillus strains on mRNA expressi
in rats fed a high cholesterol diet. The graph represents the mRNA level
deviation. Control: normal diet; HC: high cholesterol diet; HC + NS5: high ch
cholesterol diet + Lactobacillus delbrueckii subsp. bulgaricus NS12. a,b Mean
significantly (p < 0.05).NS12 strain slightly increased mRNA expression level of
LDLR. But NS5 strain seemed more effective in reducing
LDL-C level than NS12 strain, maybe other mechanisms
involved in this process. HMG-CoA reductase is the
rate-limiting enzyme in hepatic cholesterol de novo
synthesis, catalyzing the conversion of HMG-CoA to
mevalonic acid [41]. The liver HMG-CoA reductase ex-
pression is correlated with the rate of cholesterol synthe-
sis and the abundance of cholesterol sources from diet
would inhibit HMG-CoA reductase activity [42]. The
mRNA expression level of HMG-CoA reductase was sig-
nificantly reduced in high cholesterol diets fed rats com-
paring to rats fed normal diets, and the inhibitory effects
of NS5 and NS12 strains seemed more obvious, espe-
cially NS5 strain. Therefore, the reduction of serum
cholesterol levels by NS lactobacillus strains may beon levels of liver enzymes associated with cholesterol metabolism
s relative to GAPDH. The data are shown as the mean ± standard
olesterol diet + Lactobacillus plantarum NS5; HC + NS12: high-
values in each panel with different superscript letters differ
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http://www.lipidworld.com/content/12/1/67partly through inhibiting HMG-CoA reductase expression
levels. Spady et al. reported that over expression of
CYP7A1 gene effectively reduced the serum TC and LDL-
C level in hamsters fed a high-fat diet [43]. In the present
study, the liver CYP7A1 mRNA level was upregulated
higher by NS5 and NS12 strains supplementation in the
drinking water than rats fed high-cholesterol diets alone.
This may be the mechanism by which NS5 and NS12
strains could reduce serum TC and LDL-C. ACAT is the
enzyme which catalyzes the 3-OH group of cholesterol
fatty-acylated to form cholesterol esters that can be stored
in cytoplasmic lipid droplets [44]. NS5 and NS12 strains
significantly inhibited ACAT mRNA expression and re-
duced cholesterol stored in the body in the form of choles-
terol esters.Conclusions
The two NS lactobacillus strains, Lactobacillus plantarum
NS5 and Lactobacillus delbrueckii subsp. bulgaricus NS12,
exerted significant serum cholesterol lowering effects on
male SD rats fed a high-cholesterol diet. We explored the
possible mechanisms from the aspects of intestinal micro-
biota compositions and mRNA expression levels of liver
enzymes related to cholesterol metabolism, but further
studies are needed to elucidate the precise mechanism.
The NS lactobacillus strains may become more effective
and safer alternative therapies to lower serum cholesterol.
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